Perimenopausal insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Female, 40 years = age = 60 years,right-handed; (2) Meets diagnostic criteria for STRAW+10 and ICSD-3; (3) Pittsburgh Sleep Quality Index (PSQI) score >7; (4) Not taking any medication for at least 2 weeks days prior to entering the study; (5) Voluntarily participated in this study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with bilateral oophorectomy, organic ovarian lesions, premature ovarian failure, polycystic ovary syndrome, and hypothalamic amenorrhoea; (2) Those with hypertension, diabetes mellitus, coronary heart disease, obesity (BMI = 28), and other systemic diseases; (3) Those with combined cardiovascular, cerebrovascular, hepatic, renal, and hematopoietic systems and other life-threatening severe primary diseases; (4) Those who are unconscious and unable to express subjective symptoms of discomfort; (5) The person himself/herself and his/her first-degree immediate family members have a history of psychiatric system diseases, organic neuropathy, etc; (6) Insomnia caused by alcoholism and/or psychotropic substance abuse and dependence (including sleeping pills); (7) Those with severe depression and anxiety symptoms; (8) Those with severe headaches, migraine, history of head trauma and surgery; (9) Receiving estrogen, serotonin reuptake inhibitors, or other replacement therapy 4 weeks prior to enrolment; (10) History of anticoagulant use or routine use of sedatives or anxiolytics; (11) Pregnancy or planned pregnancy or breastfeeding; (12) Those with contraindications to magnetic resonance scanning such as claustrophobia, implanted metal in the body, metal braces, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical scale assessment;Multimodal neuroimaging assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuropsychological assessment; | — |
Countries
China
Contacts
Chengdu University of Traditional Chinese Medicine